Kaken Pharmaceutical Co Ltd
TSE:4521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kaken Pharmaceutical Co Ltd
TSE:4521
|
JP |
|
T
|
Tigo Energy Inc
NASDAQ:TYGO
|
US |
|
C
|
Communication & System Solution PCL
SET:CSS
|
TH |
|
Soltec Power Holdings SA
MAD:SOL
|
ES |
|
M
|
Millennium Cell Inc
OTC:MCELQ
|
US |
|
Y
|
YJM Games Co Ltd
KOSDAQ:193250
|
KR |
|
U
|
United Rentals Inc
F:UR3
|
US |
Wall St Price Targets
Price Targets Summary
Kaken Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 666.5 JPY with a low forecast of 4 040 JPY and a high forecast of 5 880 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Kaken Pharmaceutical Co Ltd's stock price target?
Price Target
4 666.5
JPY
According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 666.5 JPY with a low forecast of 4 040 JPY and a high forecast of 5 880 JPY.
What is the Revenue forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 0%.
What is the Pre-Tax Income forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
39%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -13%. The projected CAGR for the next 3 years is 39%.
What is the Net Income forecast for Kaken Pharmaceutical Co Ltd?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 3 years is 28%.
